|
| Multivitamins May Reduce Cardiovascular
Disease Risk During the six-month, randomized, double blind, placebo-controlled trial, men and women between 30 and 70 years of age were given either multivitamin supplements (as the institute’s Cooper Complete) or placebo; 67 percent of the subjects were male and 33 percent were postmenopausal females. Multivitamin supplementation reduced subjects’ C-reactive protein level by 32 percent; the greatest reductions were in subjects with elevated C-reactive protein levels at baseline. The study will appear in the December edition of The American Journal of Medicine (115, 9, 2003)
Published by BIO|ANALOGICS
|